Hims & Hers to offer at-home blood draws and lab testing
Hims & Hers Health (HIMS) is jumping 15% after the company announced that it had made an acquisition which will allow it to ...
Hims & Hers Health Inc (NYSE:HIMS) shares are soaring Wednesday after the company announced plans to introduce at-home lab ...
Investors could be overestimating the contribution of Hims & Hers' compounded GLP-1 medications to its top line. Read why I ...
Is Hims & Hers a millionaire-maker in the making? Yes! Or, at least, it can be. There is a possible future where Hims & Hers ...
Hims & Hers (HIMS) is up 22.8%, or $13.34 to $71.84.Discover the Best Stocks and Maximize Your Portfolio: See what stocks are receiving ...
The Super Bowl aired a Hims & Hers commercial that is receiving backlash for its non-FDA approved weight loss drug. This drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results